Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07643896
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk AssessmentBillionToOne Inc.Recruiting
NCT07643896Recruiting
—
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Condit...BillionToOne Inc.
NCT07646080
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma ProtuberansYanjie Zhang, MDNot Yet RecruitingPhase 2
NCT07646080Not Yet Recruiting
Phase 2
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemothera...Yanjie Zhang, MD
NCT07645885
Fermented Foods and Bone Health: Investigating the Gut-Bone Axis in Premenopausal Vegan WomenCharles University, Czech RepublicNot Yet RecruitingNot Applicable
NCT07645885Not Yet Recruiting
Not Applicable
Fermented Foods and Bone Health: Investigating the Gut-Bone Axis in Premenopausa...Charles University, Czech...
NCT07644598
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate CancerGeorgetown UniversityNot Yet RecruitingPhase 2
NCT07644598Not Yet Recruiting
Phase 2
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensificati...Georgetown University
NCT07645300
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Medical CenterNot Yet RecruitingPhase 2
NCT07645300Not Yet Recruiting
Phase 2
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Med...
NCT07645469
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer CenterNot Yet RecruitingPhase 1
NCT07645469Not Yet Recruiting
Phase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Di...Fred Hutchinson Cancer Ce...
NCT07644208
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative HepatectomyShanghai Zhongshan HospitalNot Yet RecruitingPhase 2
NCT07644208Not Yet Recruiting
Phase 2
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatoc...Shanghai Zhongshan Hospit...
NCT07645625
Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical CancerUniversity Medical Center GroningenRecruitingPhase 4
NCT07645625Recruiting
Phase 4
Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical CancerUniversity Medical Center...
NCT07644494
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: The Impact of Spontaneous Respiratory EffortJingyuan,XuCompleted
NCT07644494Completed
—
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: Th...Jingyuan,Xu
NCT07645066
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node DysfunctionShanghai Tong Ren HospitalNot Yet RecruitingNot Applicable
NCT07645066Not Yet Recruiting
Not Applicable
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients...Shanghai Tong Ren Hospita...
NCT07644312
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPGNationwide Children's HospitalNot Yet RecruitingPhase 2
NCT07644312Not Yet Recruiting
Phase 2
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG...Nationwide Children's Hos...
NCT07644299
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept StudyCiusss de L'Est de l'Île de MontréalNot Yet RecruitingNot Applicable
NCT07644299Not Yet Recruiting
Not Applicable
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Co...Ciusss de L'Est de l'Île...
NCT07644429
Biomechanical Characterisation of 3D Printed Comfort InsolesUniversity of PecsActive Not RecruitingNot Applicable
NCT07644429Active Not Recruiting
Not Applicable
Biomechanical Characterisation of 3D Printed Comfort InsolesUniversity of Pecs
NCT07643948
Impacts of HIV Treatment Regimens on Archived Drug ResistanceChinese University of Hong KongRecruiting
NCT07643948Recruiting
—
Impacts of HIV Treatment Regimens on Archived Drug ResistanceChinese University of Hon...
NCT07646262
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu UniversityRecruitingNot Applicable
NCT07646262Recruiting
Not Applicable
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu University
NCT07644741
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal PlayersFederal University of VicosaCompletedNot Applicable
NCT07644741Completed
Not Applicable
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal Pl...Federal University of Vic...
NCT07645664
Scar Management Through Serial CastingCentre hospitalier de l'Université de Montréal (CHUM)Not Yet RecruitingNot Applicable
NCT07645664Not Yet Recruiting
Not Applicable
Scar Management Through Serial CastingCentre hospitalier de l'U...
NCT07645547
Prophylactic Use of ciNPWT in Gynecologic LaparotomyUniversity Hospital Hradec KraloveNot Yet RecruitingNot Applicable
NCT07645547Not Yet Recruiting
Not Applicable
Prophylactic Use of ciNPWT in Gynecologic LaparotomyUniversity Hospital Hrade...
NCT07644351
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsNovartis PharmaceuticalsCompleted
NCT07644351Completed
—
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lym...Novartis Pharmaceuticals
NCT07646197
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver DiseaseHenry Ford Health SystemRecruitingNot Applicable
NCT07646197Recruiting
Not Applicable
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Di...Henry Ford Health System
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Phase 25 (25%)
Not Specified4 (20%)
Phase 11 (5%)
Phase 41 (5%)